Senescence-associated reprogramming promotes cancer stemness
The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Cellular senescence is a stress-responsive cell-cycle arrest program that terminates the further expansion of (pre-)malignant cells. Key signalling components of the senescence machinery, such as p16 INK4a, p21 CIP1 and p53, as well as trimethylation of lysine 9 at histone H3 (H3K9me3), also operate as critical regulators of stem-cell functions (which are collectively termed 'stemness'). In cancer cells, a gain of stemness may have profound implications for tumour aggressiveness and clinical outcome. Here we investigated whether chemotherapy-induced senescence could change stem-cell-related properties of malignant cells. Gene expression and functional analyses comparing senescent and non-senescent B-cell lymphomas from Eμ-Myc transgenic mice revealed substantial upregulation of an adult tissue stem-cell signature, activated Wnt signalling, and distinct stem-cell markers in senescence. Using genetically switchable models of senescence targeting H3K9me3 or p53 to mimic spontaneous escape from the arrested condition, we found that cells released from senescence re-entered the cell cycle with strongly enhanced and Wnt-dependent clonogenic growth potential compared to virtually identical populations that had been equally exposed to chemotherapy but had never been senescent. In vivo, these previously senescent cells presented with a much higher tumour initiation potential. Notably, the temporary enforcement of senescence in p53-regulatable models of acute lymphoblastic leukaemia and acute myeloid leukaemia was found to reprogram non-stem bulk leukaemia cells into self-renewing, leukaemia-initiating stem cells. Our data, which are further supported by consistent results in human cancer cell lines and primary samples of human haematological malignancies, reveal that senescence-associated stemness is an unexpected, cell-autonomous feature that exerts its detrimental, highly aggressive growth potential upon escape from cell-cycle blockade, and is enriched in relapse tumours. These findings have profound implications for cancer therapy, and provide new mechanistic insights into the plasticity of cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Persistent senescent cells are known to exert detrimental long-term effects on organ function and can promote tumorigenesis33,96,112,177,178.”
From COVID-19 and cellular senescence (2023) · cites this paper as [177]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the senescence programme is associated with enhanced stemness through cell- autonomous and cell- non- autonomous mechanisms”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Continuous transcriptional or, more generally, functional changes in senescent cells, and the permanent need to actively maintain senescencesupporting transcription puts the stability of cell cycle arrest at risk, occasionally leading to the restoration of proliferative properties with a potentially detrimental effect on tumour suppression 5,79 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Conversely, inactivation of Tp53 , the genes encoding either one of the three Rb family members or Suv39h1 in already senescent cells enables cell cycle re- entry out of the terminal arrest condition 5,125,126 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, retained senescence- associated gain of stemness in senescence escapers has been demonstrated in samples derived from patients with relapsed diffuse large B cell lymphoma that exhibited strong enrichment for WNT signalling activity reminiscent of senescence- associated stemness 5 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measured
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Rappsilber, J., Mann, M., & Ishihama, Y. (2007) · Nature Protocols · doi:10.1038/nprot.2007.261 · Cited by 4,641
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
Regulation of chromatin structure by site-specific histone H3 methyltransferases
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z.-W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D., et al. (2000) · Nature · doi:10.1038/35020506 · Cited by 2,845
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389
Cited by
Items 801–900 of 1,000
Liu, J., Li, H., Sun, R., Ying, G., & Liang, Z. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03818-7 · Cited by 4
Future Perspectives in Senescence-Based Therapies for Head and Neck Cancer
Palomares, B. H., Martins, M. D., Martins, M. A. T., SQUARIZE, C. H., & CASTILHO, R. M. (2025) · Cancers · doi:10.3390/cancers17121965 · Cited by 4
Integrating cuproptosis and immunosenescence: A novel therapeutic strategy in cancer treatment
Firouzjaei, A. A., & Aghaee‐Bakhtiari, S. H. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.101983 · Cited by 6
Epigenetic Insights Into Aging: Emerging Roles of Natural Products in Therapeutic Interventions
Pang, Y., Zhang, H., Li, H., Wang, X., Wei, P., Yi, L., & Lin, S. (2025) · Phytotherapy Research · doi:10.1002/ptr.70003 · Cited by 5
Interleukin-8 Dedifferentiates Primary Human Luminal Cells to Multipotent Stem Cells
Al‐Khalaf, H. H., Ghebeh, H., Wakil, S. M., Almohanna, F., & Aboussekhra, A. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00508-19 · Cited by 4
Non‐genetic and genetic rewiring underlie adaptation to hypomorphic alleles of an essential gene
Targa, A., Larrimore, K. E., Wong, C. K., Chong, Y. L., Fung, R., Lee, J., Choi, H., & Rancati, G. I. (2021) · The EMBO Journal · doi:10.15252/embj.2021107839 · Cited by 4
Saeed, M. U., Hussain, N., Zulfiqar, I., Raza, A., Ghauri, M. A., & Bilal, M. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103645 · Cited by 4
Noulet, F., & Merat, R. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.07.086 · Cited by 4
Lin, L., Schneiderman, Z., Venkatraman, A., & Kokkoli, E. (2023) · Nanoscale · doi:10.1039/d3nr00196b · Cited by 4
Cuesta‐Casanovas, L., Delgado-Martínez, J., Cornet-Masana, J. M., Carbó, J. M., Banús‐Mulet, A., Guijarro, F., Esteve, J., & Risueño, R. M. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02944-4 · Cited by 4
Histone mRNA polyadenylation‐mediated inflammation underlies various virus infections and cancers
Guo, M., Zhu, J., Hu, Z., Wang, Q., Songyang, Z., & Xiong, Y. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28826 · Cited by 4
Tan, J., Wang, C., Jin, Y., Xia, Y., Gong, B., & Zhao, Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1309138 · Cited by 4
Liang, J., Lin, Y., Liu, Y., Lin, H., Xie, Z., Wu, T., Zhang, X., Zhou, X., Tan, Z., Yin, W., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e31400 · Cited by 8
Moonlight role of PEDF in breast cancer: self-renewal inhibition in breast cancer stem cellsPreprint
Gil‐Gas, C., Sánchez‐Díez, M., Honrubia‐Gómez, P., Sánchez-Sánchez, J. L., Álvarez‐Simón, C. B., Sabater, S., Sánchez‐Sánchez, F., & Ramírez‐Castillejo, C. (2023) · Research Square · doi:10.21203/rs.3.rs-2636130/v1 · Cited by 4
Special Issue “Advances in Genome Regulation in Cancer”
Erenpreisa, J. A., Giuliani, A., & Cragg, M. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914567 · Cited by 4
Midkine at the Crossroads of Aging and Cancer
Bai, H., & Cai, S. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-4381 · Cited by 3
Cellular Senescence in Cancer: Mechanisms, Roles in Tumor Progression, and Therapeutic Implications
Yan, J., Zhang, Y., Mao, G., Yu, J., Zhou, T., & Hao, J. (2025) · MedComm – Oncology · doi:10.1002/mog2.70029 · Cited by 3
A senescence-responsive nanodrug amplifies radiotherapy efficacy
Hua, Y., Song, H., Deng, H., Tian, H., Liu, C., Wu, H., Wang, S., Shao, C., Ye, L., Ge, S., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114202 · Cited by 3
Effect of Benzo[a]pyrene on Cellular Senescence in MCF7 Breast Cancer Cells
Kitamoto, N., Haga, Y., Tsujii, Y., Kubo, M., Higashisaka, K., & Tsutsumi, Y. M. (2025) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b25-00309 · Cited by 3
A Reporter Platform to Study Therapy‐Induced Senescence in Live Cancer Cells
van de Grint, J., Huang, M., Sangers, R., Odijk, H., Reuvers, T. G. A., Heredia‐Genestar, J. M., Raams, A., Kan, T. W., Pothof, J., Kanaar, R., et al. (2025) · Small Methods · doi:10.1002/smtd.202501270 · Cited by 3
MRTF-dependent cytoskeletal dynamics drive efficient cell cycle progression
Nielsen, J. C., Benito-Jardón, M., Petrela, N. C., Diring, J., Bellamy, S., & Treisman, R. (2024) · Journal of Cell Science · doi:10.1242/jcs.264444 · Cited by 4
Elimination of docetaxel-induced senescence attenuates malignant progression in RB1-deficient CRPC
Su, H., Huang, L., Xia, W., Tang, D. G., Zhou, J., & Yang, G. (2025) · Cellular Oncology · doi:10.1007/s13402-025-01126-w · Cited by 3
Dormancy in colorectal cancer: The functional core of resistance, metastasis, and relapse
Alvarado-Ortiz, E., Moreno-Londoño, Á. P., & Sarabia-Sánchez, M. Á. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.105081 · Cited by 3
Zhang, D., Zhu, J., Zou, R., Zhang, H., Yu, B.-P., Li, P., Luo, Y., Jiang, Z., Hou, Y., & Zhang, J.-W. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117659 · Cited by 3
Non-Canonical Senescence Phenotype in Resistance to CDK4/6 Inhibitors in ER-Positive Breast Cancer
Mammadova, A., Gu, Y., Ruan, L., Badve, S., & Gökmen‐Polar, Y. (2026) · Biomolecules · doi:10.3390/biom16010093 · Cited by 3
Targeting persister cells: proactively overcoming therapy resistance in aggressive B cell lymphomas
Tao, J., Qiu, K., & Williams, M. E. (2026) · Trends in cancer · doi:10.1016/j.trecan.2025.12.007 · Cited by 3
CSNK1E sustains stemlike drug persistence in diffuse large B-cell lymphoma
Li, X., Liu, M., Shi, Q., Du, Z.-S., Fu, D., Fang, Y., Zhao, L.-J., Dai, Y., Zhang, M., Zhang, F., et al. (2026) · Blood · doi:10.1182/blood.2025031156 · Cited by 3
Yang, S. S., Chen, Y., Liu, S. R., Zuo, A., Ba, Y., Zhang, Y., Liu, B., Zhang, C., Xu, H., Luo, P., et al. (2026) · Cancer Research · doi:10.1158/0008-5472.can-25-4870 · Cited by 4
MicroRNA Biogenesis in Cell Senescence Induced by Chronic Endoplasmic Reticulum Stress
Zaichenko, D. M., Микрюкова, А. А., Astafeva, I., Malakho, S. G., Kubatiev, A. A., & Московцев, А. А. (2023) · Molecular Biology · doi:10.1134/s0026893323040192 · Cited by 4
Qu, J., Lu, Z., Cheng, Y., Deng, S., Shi, W., Liu, Q., & Ling, Y. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70415 · Cited by 3
Ochiiwa, H., Wakasa, T., Kataoka, Y., Ando, K., Oki, E., Maehara, Y., Iimori, M., & Kitao, H. (2026) · Cancer Science · doi:10.1111/cas.70329 · Cited by 3
A mutual information-based in vivo monitoring of adaptive response to targeted therapies in melanoma
Bugi-Marteyn, A., Noulet, F., Liaudet, N., & Merat, R. (2021) · Neoplasia · doi:10.1016/j.neo.2021.06.009 · Cited by 3
Hu, F., Li, H., Li, L., Gale, R. P., Song, Y., Chen, S., & Liang, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1012242 · Cited by 3
WNT-Conditioned Mechanism of Exit from Postchemotherapy Shock of Differentiated Tumour Cells
Tsydenova, I. A., Dolgasheva, D. S., Gaptulbarova, K. A., Ibragimova, M. K., Tsyganov, M. M., Kravtsova, E. A., Nushtaeva, A. A., & Литвяков, Н. В. (2023) · Cancers · doi:10.3390/cancers15102765 · Cited by 3
Wang, Y., Dai, L., Huang, R., Li, W., & Wu, W. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1203351 · Cited by 3
Advances in SEMA3F regulation of clinically high-incidence cancers
Wang, C., Song, D., Huang, Q., & Liu, Q. (2023) · Cancer Biomarkers · doi:10.3233/cbm-230085 · Cited by 3
Tumor heterogeneity from the viewpoint of pathologists
Morii, E. (2023) · Pathology International · doi:10.1111/pin.13366 · Cited by 3
Silva, A. O., Bitencourt, T. C., Vargas, J. E., Fraga, L. R., & Filippi‐Chiela, E. C. (2024) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2023-0311 · Cited by 4
The silent guardian: unraveling the roles of H3K9me3 in genome maintenance
Li, Z., & Zhang, Z. (2024) · Genome Instability & Disease · doi:10.1007/s42764-024-00131-x · Cited by 3
Todorov, T. Z., Schibli, R., Béhé, M. P., & Grünberg, J. (2024) · International Journal of Translational Medicine · doi:10.3390/ijtm4030031 · Cited by 3
Picallos-Rabina, P., Silva‐Álvarez, S. D., Antelo-Iglesias, L., Triana-Martínez, F., & Collado, M. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_5 · Cited by 3
Литвяков, Н. В., Ibragimova, M. K., Tsyganov, M. M., Deryusheva, I. V., Певзнер, А. М., Garbukov, Е. Y., Васильевич, Д. А., & Slonimskaya, E. M. (2020) · Siberian Journal of Oncology · doi:10.21294/1814-4861-2020-19-3-78-88 · Cited by 3
Li, S., Cheng, Y., Qin, M., Chen, S., Li, P., & Yang, L. (2021) · Analytical Methods · doi:10.1039/d1ay00470k · Cited by 3
Wu, G., Li, X., Zhan, Y., Fan, X., Xu, L., Chen, T., & Wang, X. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.08.023 · Cited by 3
Role of ASXL1 mutation in impaired hematopoiesis and cellular senescence
Uni, M., & Kurokawa, M. (2018) · Oncotarget · doi:10.18632/oncotarget.26423 · Cited by 3
Zhao, H., Park, Y. M., Zheng, Y., Mao, Q., Collet, C., Hu, B., Zhou, T., Lin, L., Wong, S. K., Pan, Y., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.18.631624 · Cited by 3
Molecular basis of senescence in osteoarthritis
Lawson, M. G., & Ritchison, H. M. (2024) · doi:10.32948/ajsep.2024.11.22 · Cited by 2
Ye, X., Zheng, J., Hu, D., Liu, L.-Z., Chen, F., Cai, X., Xu, Y., Li, L., Lin, J., Liu, Q., et al. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-02943-4 · Cited by 2
Kalyoncu, M., Demirci, D., Eris, S., Dayanc, B., Çakıroğlu, E., Basol, M., Uysal, M., Cakan‐Akdogan, G., Liu, F., Öztürk, M., et al. (2025) · Molecular Oncology · doi:10.1002/1878-0261.70021 · Cited by 2
Tfcp2l1 as a central integrator of hypoxia, dedifferentiation, and tumor progression
Clemente-González, C., & Carnero, A. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03501-9 · Cited by 2
Dash, A., Kulkarni, A. S., Irshad, F., Masal, D. P., Manhas, D., Nandi, U., Reddy, D. S., & Goswami, A. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115371 · Cited by 2
Sato, K., Yoshino, H., Sato, Y., Sasaki, F., Munakata, N., & Tsuruga, E. (2025) · Biomedical Reports · doi:10.3892/br.2025.2047 · Cited by 2
Pre‐Encoded IFN‐I Sensitivity Exacerbates Memory T Cell Senescence in Solid Tumors
Nguyen, A., Walsh, S. R., Deng, L., Chen, L., & Wan, Y. (2025) · Advanced Science · doi:10.1002/advs.202504474 · Cited by 2
Zhu, D., Gao, D., Lu, Y., Chen, N., Zhang, L., Zhang, L., & Wang, Y. (2025) · Pharmaceuticals · doi:10.3390/ph18111646 · Cited by 2
Cellular Senescence as a Risk Factor in Head and Neck Cancer—Diagnostic and Therapeutic Perspective
Stachowiak, M., Kostrzewa, M., Golusiński, W., Golusiński, P., Golusińska-Kardach, E., Masternak, M. M., & Rubiś, B. (2025) · Cancers · doi:10.3390/cancers18010087 · Cited by 2
Jiang, M. J., Yu, Y., Jiao, Z., Wu, T., Ning, K., Yang, Z., Chen, W., & Yang, A. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02777-4 · Cited by 2
Self-citationMontero-Vergara, J., Darski, P., Harding, A. L., & Hunter, K. D. (2026) · Cancers · doi:10.3390/cancers18071126 · Cited by 3
Yang, T., Bu, W., Xue, X., Wu, X., Zhou, Y., Chen, Y., Li, Y. S., Zhang, J., Li, P., Shen, F., et al. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104158 · Cited by 3
SLC25A1 upregulation promotes HNSCC cisplatin resistance via H3K27ac-mediated cellular senescence
Li, J., Yang, T., Li, Y., Yang, X., He, Y., Yao, Y., Zhao, S., Liu, R., Yang, Z., Zhang, H., et al. (2026) · npj Precision Oncology · doi:10.1038/s41698-026-01411-3 · Cited by 3
Filardo, A., Coscarella, I., Bria, J., Vito, A. D., Torre, D. L., Chiarella, E., Giovinazzo, A., Procopio, E., Egiziano, M. T., Lavano, A., et al. (2026) · Cancers · doi:10.3390/cancers18081220 · Cited by 2
Protein phosphatase 2A regulates senescence and immunogenicity in medulloblastoma models
Ho, W. S., Mondal, I., Liu, J., Sun, R., Huo, J., Gao, C., Das, O., Tieu, D., Sun, J., Lin, H., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci196753 · Cited by 2
Hartono, M., Ge, J., Denholm, M., Ellis, M. G., Henríquez, J. A., Baker, A., Rintoul, R. C., Euser, T. G., Fruk, L., & Muñoz‐Espín, D. (2026) · Nature Aging · doi:10.1038/s43587-026-01116-z · Cited by 2
Hess, M. S., Al-Shami, K. M., Caballero, C. D., Haenlin, J., Chaves‐Filho, A. B., Schlicker, L., Poeller, P., Vogel, F. C. E., Koltsaki, I., Gedik, D., et al. (2026) · Cell Death and Differentiation · doi:10.1038/s41418-026-01766-x · Cited by 2
YTHDC1 drives senescence evasion in ovarian cancer through m6A-mediated TERT stabilization
Wang, F., Zhao, Z., Li, Z., Chen, X., Lu, W., Yao, S., Xi, J., Sun, Y., Luo, H., Feng, Q., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08896-7 · Cited by 2
Self-citationTilting the balance of life and death: navigating DNA replication stress in cancer therapy
Lo, N., & Kim, H. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01745-9 · Cited by 3
Molecular mechanisms and recent advances in cellular senescence
Hussain, A., Tatar, M., & Gong, R. (2026) · Cell & Bioscience · doi:10.1186/s13578-026-01596-x · Cited by 3
Tan, J., Wen, T., Liu, J. S., & Ru, X. (2026) · Journal of Hematology & Oncology · doi:10.1186/s13045-026-01828-0 · Cited by 2
Phenotypic plasticity: the emergence of cancer stem cells and collective cell migration
Porta, C. A. M. L., & Zapperi, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817996-3.00023-2 · Cited by 3
Repair, regeneration and rejuvenation require un-entangling pluripotency from senescence
TABIBZADEH, S. S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101663 · Cited by 3
Role of Senescence-Resumed Proliferation in Keloid Pathogenesis
Wang, C., Wu, C.-W., & Lin, T.-Y. (2023) · Future Pharmacology · doi:10.3390/futurepharmacol3010014 · Cited by 2
Understanding cardiac senescence one cell type at a time
Sen, P., & Gurha, P. (2023) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2023.16 · Cited by 2
Educational aspiration and school climate of secondary school students: A study of district Lucknow
Hashmi, A. T., & Shakir, M. (2023) · International journal of applied research · doi:10.22271/allresearch.2023.v9.i6b.10924 · Cited by 2
microRNA Biogenesis during Cellular Senesence Induced by Chronic Stress of the Endoplasmic Reticulum
Kubatiev, A. A., Московцев, А. А., Zaichenko, D. M., Микрюкова, А. А., Astafeva, I., & Malakho, S. G. (2023) · Molecular Biology · doi:10.31857/s0026898423040250 · Cited by 2
Oncogene-induced senescence in meningiomas—an immunohistochemical study
Mijajlović, V., Miler, M., Ilić, R., Rašić, D., Dunđerović, D., Raičević, S., Soldatović, I., Luka, S. R. D., & Manojlović-Gačić, E. (2023) · Journal of Neuro-Oncology · doi:10.1007/s11060-023-04532-y · Cited by 2
Kim, J. W., Bae, S.-H., Moon, Y., Kim, E. K., Kim, Y.-J., Park, Y. G., Han, M.-R., & Sohn, J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0309749 · Cited by 3
Arachidonoylethanolamide promotes cellular senescence in a human glioblastoma cell line
Zapi-Colín, L. Á., Dotor-Hernández, J. E., Contreras, I., & Estrada, J. A. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.151235 · Cited by 2
Niculescu, V. F. (2025) · Academia molecular biology and genomics. · doi:10.20935/acadmolbiogen7755 · Cited by 2
Tian, M., Cui, H., Wang, X., Hu, H., Dong, L., Xiao, S., Qu, C., Wang, P., Zhi, H., Ning, S., et al. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf469 · Cited by 3
The Effect of the Human Plasma Molecule GHK-Cu on Stem Cell Actions and Expression of Relevant Genes
Pickart, L., & Margolina, A. (2018) · OBM Geriatrics · doi:10.21926/obm.geriatr.1803009 · Cited by 3
Intracellular Iron Concentration and Distribution Have Multiple Effects on Cell Cycle Events
Seligman, P. A., & Siriwardana, G. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.86399 · Cited by 2
Mechanisms of cell senescence in aging
von Zglinicki, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-815962-0.00003-2 · Cited by 3
Convergent Usage of Amino Acids in Human Cancers as a Reversed Process of Tissue Development
Luo, Y., & Liang, H. (2021) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2021.08.004 · Cited by 2
Golan, H., Mechoulam, R., Smoum, R., Cohen-Zada, E., Pri‐Chen, S., Wiener, S., Grinberg, I., Bar‐Lev, D. D., Haj, C. G., Fisher, T., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10071552 · Cited by 2
Zhou, X., Zhou, Q., Zhou, D., Li, F., Zhang, C., & Yang, Y. (2022) · Translational Cancer Research · doi:10.21037/tcr-21-2438 · Cited by 2
Li, Y., Nong, X., Deng, J., & Yang, G. (2022) · Physiology International · doi:10.1556/2060.2022.00191 · Cited by 2
Popper, H. (2021) · Springer eBooks · doi:10.1007/978-3-030-55743-0_17 · Cited by 2
Martínez‐Zamudio, R. I., & Herbig, U. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_38-1 · Cited by 2
González‐Gualda, E., Macías, D., Morsli, S., Martín, J., Ou, H., Denholm, M., Olan, I., Hoffmann, R. J., Dane, M. A., Veroutis, D., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.01.502019 · Cited by 2
Epigenetic Disordering Drives Stemness, Senescence Escape and Tumor HeterogeneityPreprint
Magnani, E., Macchi, F., Randic, T., Chen, C., Madakashira, B. P., Ranjan, S., Eski, S. E., Singh, S. P., & Sadler, K. C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.29.629346 · Cited by 4
A one-two punch against cancer: combining CDK4 inhibitors with lysosomotropic agents
Ferbeyre, G. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00396-2 · Cited by 2
Antiaging for Ph-like ALL: targeting senescence
Iacobucci, I. (2025) · Blood · doi:10.1182/blood.2024027815 · Cited by 2
Characterization of hyperoxia-induced senescent lung macrophages in neonatal micePreprint
Lin, F., Lu, W., Dennery, P. A., & Yao, H. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.09.652066 · Cited by 2
Yan, M., & Liu, Q. (2023) · Frontiers of Medicine · doi:10.1007/s11684-022-0975-5 · Cited by 1
Jing, F., Mu, J., Liu, J., Hu, C., Wu, F., & Gao, Q. (2025) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2025.106242 · Cited by 1
Esimbekova, A. R., Belenyuk, V. D., Савченко, А. А., & Ruksha, T. G. (2025) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.42808 · Cited by 1
GNF-5837 alleviates intervertebral disc ageing by upregulating glutathione peroxidase 7
Xu, Y., Chen, R., Zhuang, Y., & Xu, W. (2025) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320251343365 · Cited by 1
Induction of cancer stem cells from mouse fibroblasts
Shabrish, S., Naorem, L. D., Mohanty, S., Kumar, R., Lopes, R., Akhtar, N., Khare, N. K., Joshi, R., Sawant, R., Raghuram, G. V., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-09686-5 · Cited by 1
Александровна, П. Н., Ivanova, E. S., & Zamkova, M. A. (2025) · Biochemistry (Moscow) · doi:10.1134/s0006297925601005 · Cited by 1
Wu, Y.-W., Jiang, Z.-Z., Wang, J., Ye, S.-Q., Zou, W.-L., & Tan, N. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107733 · Cited by 1
Metadata
- Authors
- Milanovic, M., Fan, D. N. Y., Belenki, D., Däbritz, J. H. M., Zhao, Z., Yu, Y., Dörr, J. R., Dimitrova, L., Lenze, D., Monteiro Barbosa, I. A., Mendoza-Parra, M. A., Kanashova, T., Metzner, M., Pardon, K., Reimann, M., Trumpp, A., Dörken, B., Zuber, J., Gronemeyer, H., Hummel, M., Dittmar, G., Lee, S., & Schmitt, C. A.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- German Cancer Research Center (DE)
- Memorial Sloan Kettering Cancer Center (US)
- Max Delbrück Center (DE)
- Centre National de la Recherche Scientifique (FR)
- Research Institute of Molecular Pathology (AT)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Corresponding author
- Schmitt, Clemens A.
- ORCID
- Venue
- Nature
- Published
- 2017-12-20
- Volume
- 553
- Issue
- 7686
- Pages
- 96-100
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2777786283
- Cited by
- 1,131
- References
- 60
- Citations by year
- 2026: 110 · 2025: 137 · 2024: 154 · 2023: 181 · 2022: 149 · 2021: 140 · 2020: 125 · 2019: 84 · 2018: 49 · 2017: 1
- FWCI
- 52.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- cellular senescence, cancer stem cells, chemotherapy-induced senescence, senescence escape, Wnt signaling, H3K9me3, p53, p16INK4a, p21, B-cell lymphoma, acute lymphoblastic leukemia, acute myeloid leukemia, hematologic malignancies, clonogenic growth, self-renewal
- MeSH terms
- Animals, Clone Cells, Female, Humans, Male, Mice, Transgenic, Phenotype, Neoplastic Stem Cells, Biomarkers, Lymphoma, B-Cell, Cellular Senescence, Cell Line, Tumor, Cell Proliferation, Mice, Cell Cycle Checkpoints, Wnt Signaling Pathway, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.